Research Topics
| Alexandra J LanskySummaryAffiliation: Cardiovascular Research Foundation Country: USA Publications
| Collaborators
|
Detail Information
Publications
Quantitative angiographic methods for appropriate end-point analysis, edge-effect evaluation, and prediction of recurrent restenosis after coronary brachytherapy with gamma irradiationAlexandra J Lansky
Cardiovascular Research Foundation and Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
J Am Coll Cardiol 39:274-80. 2002....
Non-polymer-based paclitaxel-coated coronary stents for the treatment of patients with de novo coronary lesions: angiographic follow-up of the DELIVER clinical trialAlexandra J Lansky
Cardiovascular Research Foundation and Lenox Hill Heart and Vascular Institute, 55 E 59th St, 6th Floor, New York, NY 10022 1112, USA
Circulation 109:1948-54. 2004..The DELIVER trial was a prospective, randomized, blinded, multicenter clinical evaluation of the non-polymer-based paclitaxel-coated ACHIEVE stent compared with the stainless steel Multi-Link (ML) PENTA stent...
Comparison of differences in outcome after percutaneous coronary intervention in men versus women <40 years of ageAlexandra J Lansky
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
Am J Cardiol 93:916-9. 2004....
Gender differences in outcomes after primary angioplasty versus primary stenting with and without abciximab for acute myocardial infarction: results of the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trAlexandra J Lansky
College of Physicians and Surgeons, Columbia University, and the Cardiovascular Research Foundation, New York, NY 10022, USA
Circulation 111:1611-8. 2005..Whether contemporary interventional treatment strategies have improved outcomes for women compared with men is unknown...
Treatment of coronary artery perforations complicating percutaneous coronary intervention with a polytetrafluoroethylene-covered stent graftAlexandra J Lansky
Cardiovascular Research Foundation, New York, New York, USA
Am J Cardiol 98:370-4. 2006..The CSG may be a reliable and highly effective treatment option for sealing coronary perforations complicating percutaneous coronary interventions...
Quantitative angiographic methods for bifurcation lesions: a consensus statement from the European Bifurcation GroupAlexandra Lansky
Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York 10022, USA
Catheter Cardiovasc Interv 73:258-66. 2009....
Impact of gender and antithrombin strategy on early and late clinical outcomes in patients with non-ST-elevation acute coronary syndromes (from the ACUITY trial)Alexandra J Lansky
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
Am J Cardiol 103:1196-203. 2009..In women, bivalirudin monotherapy compared with a GPI-based strategy resulted in significantly decreased bleeding but similar rates of 1-year composite ischemia and mortality...
Gender-based evaluation of the XIENCE V everolimus-eluting coronary stent system: clinical and angiographic results from the SPIRIT III randomized trialAlexandra J Lansky
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York 10022, USA
Catheter Cardiovasc Interv 74:719-27. 2009..We evaluated the role of gender on clinical and angiographic results of the everolimus-eluting stent in the SPIRIT III trial...
Quantitative coronary angiography in regression trials: a review of methodologic considerations, endpoint selection, and limitationsAlexandra J Lansky
Cardiovascular Research Foundation and Lenox Hill Heart and Vascular Institute, Lenox Hill Hospital, New York, New York 10022, USA
Am J Cardiol 89:4B-9B. 2002..Angiographic methods and criteria for assessing disease progression each have distinct advantages and disadvantages, which accounts for the methodologic diversity seen in clinical trials...
Outcomes of percutaneous and surgical revascularization in womenAlexandra J Lansky
Cardiovascular Research Foundation, New York, NY 10022, USA
Prog Cardiovasc Dis 46:305-19. 2004..This paper reviews the specific pathophysiology of CAD in women as it influences outcome and current interventional and surgical treatment modalities and outcomes for stable and unstable coronary artery syndromes...
A risk score to predict bleeding in patients with acute coronary syndromesRoxana Mehran
Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York 10032, USA
J Am Coll Cardiol 55:2556-66. 2010..The aim of this study was to develop a practical risk score to predict the risk and implications of major bleeding in acute coronary syndromes (ACS)...
Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trialEugenia Nikolsky
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York 10022, USA
J Am Coll Cardiol 54:1293-302. 2009..We assessed the incidence, predictors, and outcomes of gastrointestinal bleeding (GIB) in patients with acute coronary syndromes (ACS)...
Impact of anemia on clinical outcomes of patients with ST-segment elevation myocardial infarction in relation to gender and adjunctive antithrombotic therapy (from the HORIZONS-AMI trial)Kenichi Tsujita
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
Am J Cardiol 105:1385-94. 2010..Paradoxically, in this post hoc analysis, the reductions in major bleeding and mortality in ST elevation myocardial infarction afforded by bivalirudin occurred primarily in patients without baseline anemia...
Impact of smoking on outcomes of patients with ST-segment elevation myocardial infarction (from the HORIZONS-AMI Trial)Kenji Goto
Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
Am J Cardiol 108:1387-94. 2011..Bivalirudin monotherapy compared to UFH plus a GPI decreased major bleeding regardless of smoking status but may have different effects on individual components of ischemic events...
Long-term impact of chronic kidney disease in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial InAdam J Saltzman
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
JACC Cardiovasc Interv 4:1011-9. 2011..This study sought to investigate the impact of chronic kidney disease (CKD) in patients undergoing percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) with different antithrombotic strategies...
Impact of chronic kidney disease on early (30-day) and late (1-year) outcomes of patients with acute coronary syndromes treated with alternative antithrombotic treatment strategies: an ACUITY (Acute Catheterization and Urgent Intervention Triage strategY)Roxana Mehran
Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York 10032, USA
JACC Cardiovasc Interv 2:748-57. 2009....
Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarctionGeorge D Dangas
Cardiovascular Institute, Mount Sinai Medical Center, One Gustave L Levy Place, New York, NY 10029, USA
Circulation 123:1745-56. 2011..Concerns persist regarding the risk of stent thrombosis in the setting of primary percutaneous coronary intervention for ST-segment elevation myocardial infarction...
Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary interventionEugenia Nikolsky
Cardiovascular Research Foundation, and Lenox Hill Heart and Vascular Institute, New York, New York, USA
Am J Cardiol 94:300-5. 2004..Contrast-induced nephropathy was among the independent predictors of a 1-year mortality rate (OR 2.75, p <0.001)...
Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent eraTereza Pucelikova
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY, USA
Am J Cardiol 101:63-8. 2008..025). In conclusion, our data show that patients with SVG lesions remain a high-risk subgroup with worse outcomes after percutaneous coronary intervention compared with native vessel disease even in the era of drug-eluting stents...
The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: study design and rationaleRoxana Mehran
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY 10032, USA
Am Heart J 156:44-56. 2008..Newer pharmacologic agents and drug-eluting stents may address both of these issues...
Impact of baseline platelet count in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction (from the CADILLAC trial)Eugenia Nikolsky
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
Am J Cardiol 99:1055-61. 2007..03, 95% CI 1.00 to 1.06, p = 0.055) at 1 year. In conclusion, a higher baseline platelet count in patients with AMI is a powerful independent predictor of death and reinfarction within the first year after primary PCI...
Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) TrialEugenia Nikolsky
Cardiovascular Research Foundation, New York, New York 10022, USA
J Am Coll Cardiol 44:547-53. 2004..26; p = 0.048) and one-year mortality (hazard ratio, 2.38; p = 0.016). CONCLUSIONS: Anemia at baseline in patients with AMI undergoing primary PCI is common, and is strongly associated with adverse outcomes and increased mortality...
Creatine kinase-MB enzyme elevation and long-term clinical events after successful coronary stenting in lesions with ruptured plaqueKenichi Fujii
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York, USA
Am J Cardiol 95:355-9. 2005..Plaque rupture morphology is associated with higher periprocedural CK-MB release and worse 1-year clinical outcome in patients treated with coronary stenting...
Prognostic impact of blood transfusion after primary angioplasty for acute myocardial infarction: analysis from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) TrialEugenia Nikolsky
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY 10032, USA
JACC Cardiovasc Interv 2:624-32. 2009..We sought to determine the relationship between red blood cell (RBC) transfusion and clinical outcomes in patients undergoing primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI)...
Comparison between ticlopidine and clopidogrel in patients undergoing primary stenting in acute myocardial infarction: results from the CADILLAC trialAlexandra J Lansky
Columbia University Medical Center, Department of Cardiology, Cardiovascular Research Foundation, New York, New York 10022, USA
Catheter Cardiovasc Interv 72:917-24. 2008..The aim of this article is to examine whether clopidogrel and ticlopidine treatments produce similar clinical outcomes for patients receiving primary stenting for acute myocardial infarction (AMI)...
Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationaleGregg W Stone
Columbia University Medical Center, Cardiovascular Research Foundation, New York, NY 10022, USA
Am Heart J 148:764-75. 2004..Pilot trials suggest that the thrombin-specific anticoagulant bivalirudin may improve clinical outcomes in ACS...
Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intRoxana Mehran
Department of Cardiology, Mount Sinai Medical Center, New York, New York, USA
JACC Cardiovasc Interv 4:654-64. 2011..This study sought to develop a risk score predictive of bleeding in patients undergoing percutaneous coronary intervention (PCI) and to investigate the impact of bleeding on subsequent mortality...
Outcomes of patients with coronary artery perforation complicating percutaneous coronary intervention and correlations with the type of adjunctive antithrombotic therapy: pooled analysis from REPLACE-2, ACUITY, and HORIZONS-AMI trialsJacob A Doll
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, USA
J Interv Cardiol 22:453-9. 2009..The lack of a specific counteragent to bivalirudin may complicate the management of patients with coronary artery (CA) perforation during percutaneous coronary intervention (PCI)...
Effectiveness of drug-eluting stent implantation for patients with unprotected left main coronary artery stenosisYoung Hak Kim
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
Am J Cardiol 101:801-6. 2008..However, bifurcation stenosis remains a significant predictor of unfavorable clinical outcome...
An evaluation of fluoroscopy time and correlation with outcomes after percutaneous coronary interventionEugenia Nikolsky
Columbia University Medical Center and the Cardiovascular Research Foundation, New York City, NY 10022, USA
J Invasive Cardiol 19:208-13. 2007..We evaluated short-term prognosis and resource utilization of consecutive patients treated with percutaneous coronary intervention (PCI) as a function of fluoroscopy time...
Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trialRoxana Mehran
Columbia University Medical Center New York Presbyterian Hospital and the Cardiovascular Research Foundation, New York, NY, USA
Lancet 374:1149-59. 2009..Here, we assess whether these initial benefits were maintained at 1 year of follow-up...
Intravascular ultrasound comparison of the retrograde versus antegrade approach to percutaneous intervention for chronic total coronary occlusionsKenichi Tsujita
Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York 10022, USA
JACC Cardiovasc Interv 2:846-54. 2009..We sought to evaluate the results of the antegrade versus retrograde chronic total occlusion (CTO) technique with intravascular ultrasound (IVUS) imaging...
Nonuniform strut distribution correlates with more neointimal hyperplasia after sirolimus-eluting stent implantationHideo Takebayashi
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, NY 10022, USA
Circulation 110:3430-4. 2004..01 and P<0.01), minimum lumen area (P<0.01 and P<0.01), and IH thickness (P<0.01 and P<0.01). CONCLUSIONS: The number and distribution of stent struts affect the amount of neointima after SES implantation...
Coronary plaque composition, morphology, and outcomes in patients with and without chronic kidney disease presenting with acute coronary syndromesUsman Baber
Mount Sinai Medical Center, New York, New York, USA
JACC Cardiovasc Imaging 5:S53-61. 2012..This study sought to evaluate the impact of chronic kidney disease (CKD) on coronary atherosclerotic plaque composition, morphology, and outcomes in patients with acute coronary syndromes (ACS)...
Radial access in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty in acute myocardial infarction: the HORIZONS-AMI trialPhilippe Genereux
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY, USA
EuroIntervention 7:905-16. 2011..There is a paucity of data comparing the TR approach with the TF approach in patients with STEMI treated with primary PCI and contemporary anticoagulant regimens...
Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent Bimmer E Claessen
New York Presbyterian Hospital, Columbia University, New York, NY, USA
JACC Cardiovasc Interv 4:1209-15. 2011..The aim of this study was to investigate the impact of reference vessel diameter (RVD) and lesion length (LL) on the relative safety and efficacy of everolimus-eluting stents (EES) and paclitaxel-eluting stents (PES)...
Prognostic significance of coronary thrombus in patients undergoing percutaneous coronary intervention for acute coronary syndromes: a subanalysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trialKenji Goto
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
JACC Cardiovasc Interv 4:769-77. 2011....
Outcome after acute incomplete sirolimus-eluting stent apposition as assessed by serial intravascular ultrasoundMasashi Kimura
The Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
Am J Cardiol 98:436-42. 2006..Although most ISAs after SES implantation do not resolve completely, the incidence of restenosis or thrombosis is not affected...
Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents: the Acute Catheterization and Urgent Intervention Triage Strategy trialJiro Aoki
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY, USA
Circulation 119:687-98. 2009..The clinical and angiographic predictors of early (<30 days) stent thrombosis (ST) have not been reported in high-risk patients with acute coronary syndromes...
Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarctionGregg W Stone
Columbia University Medical Center and New York Presbyterian Hospital and the Cardiovascular Research Foundation, New York, NY 10022, USA
N Engl J Med 360:1946-59. 2009....
Impact of thienopyridine administration prior to primary stenting in acute myocardial infarctionLeRoy E Rabbani
Columbia University Medical Center, Cardiovascular Research Foundation, New York, New York 10032, USA
J Interv Cardiol 22:378-84. 2009....
5-year follow-up of polytetrafluoroethylene-covered stents compared with bare-metal stents in aortocoronary saphenous vein grafts the randomized BARRICADE (barrier approach to restenosis: restrict intima to curtail adverse events) trialGregg W Stone
Department of Medicine, Division of Cardiology, Columbia University, Medical Center New York Presbyterian Hospital, Cardiovascular Research Foundation, New York 10022, USA
JACC Cardiovasc Interv 4:300-9. 2011..We sought to evaluate the utility of the JOSTENT polytetrafluoroethylene (PTFE) stent-graft (Jomed GmbH, Rangendingen, Germany) in patients with diseased saphenous vein grafts (SVGs) undergoing percutaneous coronary intervention (PCI)...
Comparison of the angiographic outcomes after beta versus gamma vascular brachytherapy for treatment of in-stent restenosisKazuyuki Shirai
Cardiovascular Research Foundation, Lenox Hill Hospital, New York, New York 10022, USA
Am J Cardiol 92:1409-13. 2003..In matched lesions, beta and gamma VBT achieved similar reductions in treated segment restenosis and recurrent lesion length compared with placebo...
Intravascular brachytherapy for native coronary ostial in-stent restenotic lesionsCostantino O Costantini
Cardiovascular Research Foundation, Lenox Hill Hospital, 55 East 59th Street, 6th Floor, New York, New York, NY 10022, USA
J Am Coll Cardiol 41:1725-31. 2003..Vascular brachytherapy with either gamma or beta sources results in significant and similar reductions in restenosis compared with placebo. Similar benefits after VBT prevail in true aorto-ostial lesions...
Effect of everolimus-eluting stents in different vessel sizes (from the pooled FUTURE I and II trials)Yoshihiro Tsuchiya
The Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York, USA
Am J Cardiol 98:464-9. 2006..The EES appears to be effective for treatment of de novo coronary lesions in decreasing neointimal proliferation at 6-month follow-up compared with BMSs, regardless of vessel size...
Volumetric intravascular ultrasound assessment of neointimal hyperplasia and nonuniform stent strut distribution in sirolimus-eluting stent restenosisKoichi Sano
Columbia University Medical Center and Cardiovascular Research Foundation, New York, NY, USA
Am J Cardiol 98:1559-62. 2006....
Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trialGregg W Stone
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY 10022, USA
Lancet 369:907-19. 2007..The aim of this study was to assess anticoagulation with the direct thrombin inhibitor bivalirudin during percutaneous coronary intervention in individuals with moderate and high-risk acute coronary syndromes...
Intravascular ultrasound assessment of the incidence and predictors of edge dissections after drug-eluting stent implantationXuebo Liu
Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
JACC Cardiovasc Interv 2:997-1004. 2009..We used intravascular ultrasound (IVUS) to assess incidence, predictors, morphology, and angiographic findings of edge dissections after drug-eluting stent (DES) implantation...
Comparison of clinical outcomes using stents versus no stents after percutaneous coronary intervention for proximal left anterior descending versus proximal right and left circumflex coronary arteriesDale T Ashby
Cardiovascular Research Foundation, Lenox Hill Heart and Vascualr Institute, New York, New York 10022, USA
Am J Cardiol 89:1162-6. 2002..A stenting strategy for proximal LAD stenoses appears to attenuate the differences of clinical restenosis noted after non-stent PCI...
Clinical and angiographic predictors of short- and long-term ischemic events in acute coronary syndromes: results from the Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trialAlexandra J Lansky
Columbia University Medical Center, New York, NY 10022, USA
Circ Cardiovasc Interv 3:308-16. 2010..We sought to identify the clinical and angiographic predictors of cardiac ischemic events in patients with ACSs treated with an early invasive strategy...
Predictors of outcomes in medically treated patients with acute coronary syndromes after angiographic triage: an Acute Catheterization And Urgent Intervention Triage Strategy (ACUITY) substudyKenji Goto
Cardiovascular Research Foundation, 111 E 59th St, 11th Floor, New York, NY 10022, USA
Circulation 121:853-62. 2010..We sought to assess the predictors of adverse cardiac events in patients with acute coronary syndrome assigned to medical management...
Increased CK-MB release is a "trade-off" for optimal stent implantation: an intravascular ultrasound studyIoannis Iakovou
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
J Am Coll Cardiol 42:1900-5. 2003..Increased periprocedural CK-MB release appears as a trade-off for optimal stent implantation and lower clinical restenosis...
Prognostic significance of cerebrovascular and peripheral arterial disease in patients having percutaneous coronary interventionsEugenia Nikolsky
Cardiovascular Research Foundation, New York, NY 10022, USA
Am J Cardiol 93:1536-9. 2004..These 2 conditions are associated with adverse in-hospital and 1-year outcomes and independently predict early and 1-year mortality...
Usefulness of minimum stent cross sectional area as a predictor of angiographic restenosis after primary percutaneous coronary intervention in acute myocardial infarction (from the HORIZONS-AMI Trial IVUS substudy)So Yeon Choi
Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
Am J Cardiol 109:455-60. 2012....
Impact and determinants of left ventricular function in patients undergoing primary percutaneous coronary intervention in acute myocardial infarctionAmir Halkin
Cardiovascular Research Foundation, New York, New York, USA
Am J Cardiol 96:325-31. 2005..Simple clinical and angiographic features readily available at the time of primary angioplasty also predict convalescent LVEF and are thus of prognostic utility...
A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validationRoxana Mehran
Cardiovascular Research Foundation, Columbia University Medical Center, New York, New York 10022, USA
J Am Coll Cardiol 44:1393-9. 2004..4% to 55.9% for a low and high risk score, respectively). CONCLUSIONS: The risk of CIN after PCI can be simply assessed using readily available information. This risk score can be used for both clinical and investigational purposes...
Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosisKenichi Fujii
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, NY 10021, USA
Circulation 109:1085-8. 2004..03). A gap between SESs was identified in 3 of 11 recurrences versus 1 of 19 nonrecurrent lesions. CONCLUSIONS: Stent underexpansion is a significant cause of failure after SES implantation treatment of ISR...
Intravascular ultrasound assessment of lesions with target vessel failure after sirolimus-eluting stent implantationHideo Takebayashi
Cardiovascular Research Foundation, New York, New York, USA
Am J Cardiol 95:498-502. 2005....
Volumetric intravascular ultrasound analysis of Paclitaxel-eluting and bare metal stents in acute myocardial infarction: the harmonizing outcomes with revascularization and stents in acute myocardial infarction intravascular ultrasound substudyAkiko Maehara
Columbia University Medical Center, New York, NY 10022, USA
Circulation 120:1875-82. 2009....
Bifurcation coronary lesions treated with the "crush" technique: an intravascular ultrasound analysisRicardo A Costa
Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York 10022, USA
J Am Coll Cardiol 46:599-605. 2005..CONCLUSIONS: In the majority of bifurcation lesions treated with the crush technique, the smallest minimum stent area appeared at the SB ostium. This may contribute to a higher restenosis rate at this location...
5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stentsAdriano Caixeta
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
J Am Coll Cardiol 54:894-902. 2009..Five-year clinical follow-up has been scheduled per protocol by the 4 Cypher (Cordis/Johnson & Johnson, Warren, New Jersey) sirolimus-eluting stent (SES) versus bare-metal stent (BMS) randomized trials...
Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk scoreAmir Halkin
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York 10022, USA
J Am Coll Cardiol 45:1397-405. 2005..Of note, measurement of baseline left ventricular function is the single most powerful predictor of survival and should be incorporated into risk score models...
Correlation of coronary arterial remodeling determined by intravascular ultrasound with angiographic diameter reduction of 20% to 60%Makoto Hirose
Cardiovascular Research Foundation, New York, NY 10021, USA
Am J Cardiol 92:141-5. 2003..7) were similar. Negative remodeling is frequently observed in lesions with intermediate stenosis. This suggests that negative remodeling occurs early in lesion formation...
Intravascular ultrasonic differences between aorto-ostial and shaft narrowing in saphenous veins used as aortocoronary bypass graftsKoichi Sano
Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
Am J Cardiol 97:1463-6. 2006..These IVUS differences may account for some of the location-specific differences in interventional complications...
Optimal final lumen area and predictors of target lesion revascularization after stent implantation in small coronary arteriesIoannis Iakovou
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
Am J Cardiol 92:1171-6. 2003..Therefore, there does not appear to be any "downside" to aggressive stent implantation strategies in small vessels. In contrast, IVUS allows maximization of final lumen dimensions to minimize clinical restenosis...
The relationship between attenuated plaque identified by intravascular ultrasound and no-reflow after stenting in acute myocardial infarction: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trialXiaofan Wu
Columbia University Medical Center, New York, New York, USA
JACC Cardiovasc Interv 4:495-502. 2011..The aim of this study was to understand the impact of attenuated plaque on distal embolization during stent implantation in patients with acute myocardial infarction (AMI)...
Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trialGregg W Stone
Columbia University Medical Center, The Cardiovascular Research Foundation, 111 E 59th St, 11th Floor, New York, NY 10022, USA
JAMA 299:1903-13. 2008....
Implications of the presence and length of "geographic miss" on restenosis and the edge phenomenon in the INHIBIT trialCostantino O Costantini
Cardiovascular Research Foundation, New York, New York 10022, USA
Am J Cardiol 91:1261-5. 2003
New-device angioplasty in women: clinical outcome and predictors in a 7,372-patient registryAlexandra J Lansky
Cardiac Catheterization Laboratory and the Women s Cardiac Health Initiative, Lenox Hill Hospital, New York City, NY 10022, USA
Epidemiology 13:S46-51. 2002..To gain insight into the outcome of women after new-device angioplasty, we reviewed the early and late clinical outcome of 7,372 patients undergoing new-device angioplasty between 1991 and 1996 at the Washington Hospital Center...
Relation between the degree of procedural anticoagulation and complications after coronary stent implantationDale T Ashby
Cardiovascular Research Foundation and Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
Am J Cardiol 92:319-22. 2003..High levels of procedural anticoagulation with heparin were found to increase hemorrhagic complications without improving clinical or angiographic outcomes...
Clinical outcomes after heterogeneous overlap stenting with drug-eluting stents and bare-metal stents for de novo coronary artery narrowingsJiro Aoki
Center for Interventional Vascular Therapy, Columbia University Medical Center, New York, NY, USA
Am J Cardiol 101:58-62. 2008..In conclusion, the incidence of DES and BMS overlap stenting is rare in daily practice, but this procedure is associated with a high rate of target vessel revascularization...
Gender-based outcomes after paclitaxel-eluting stent implantation in patients with coronary artery diseaseAlexandra J Lansky
Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
J Am Coll Cardiol 45:1180-5. 2005..28 [95% CI 0.11 to 0.74], p = 0.01). CONCLUSIONS: The benefits of the paclitaxel-eluting stent in reducing clinical and angiographic restenosis are generalizable to women...
Impact of in-hospital acquired thrombocytopenia in patients undergoing primary angioplasty for acute myocardial infarctionEugenia Nikolsky
Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
Am J Cardiol 96:474-81. 2005..0% vs 3.9%, p = 0.03) in patients who developed thrombocytopenia. In conclusion, thrombocytopenia that develops after primary PCI for AMI, although uncommon, is associated with increased hemorrhagic complications and decreased survival...
Everolimus-eluting versus paclitaxel-eluting stents in coronary artery diseaseGregg W Stone
Columbia University Medical Center New York Presbyterian Hospital and the Cardiovascular Research Foundation, New York, NY 10022, USA
N Engl J Med 362:1663-74. 2010..Previous studies have established the superiority of coronary everolimus-eluting stents over paclitaxel-eluting stents with respect to angiographic findings. However, these trials were not powered for superiority in clinical end points...
Incidence, mechanisms, predictors, and clinical impact of acute and late stent malapposition after primary intervention in patients with acute myocardial infarction: an intravascular ultrasound substudy of the Harmonizing Outcomes with Revascularization aNing Guo
Columbia University Medical Center and Cardiovascular Research Foundation, New York, NY, 10022, USA
Circulation 122:1077-84. 2010..The incidence and mechanisms of acute and late stent malapposition after primary stent implantation in ST-segment elevation myocardial infarction remain unclear...
The relative effects of abciximab and tirofiban on platelet inhibition and C-reactive protein during coronary interventionAdam J Saltzman
Cardiovascular Medicine and the Center for Interventional Vascular Therapy, Columbia University Medical Center, 161 Fort Washington Avenue, New York, NY, 10032, USA
J Invasive Cardiol 22:2-6. 2010..We sought to compare the efficacy of tirofiban and abciximab on platelet inhibition as well as their effects of platelet inhibition on C-reactive protein levels during percutaneous coronary intervention (PCI)...
Usefulness of the angiographic pattern of in-stent restenosis in predicting the success of gamma vascular brachytherapyCostantino O Costantini
Cardiovascular Research Foundation, New York, New York 10021, USA
Am J Cardiol 92:1214-7. 2003....
Gender differences in clinical outcome after coronary artery stenting with use of glycoprotein IIb/IIIa inhibitorsIoannis Iakovou
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
Am J Cardiol 89:976-9. 2002
Angiographic results of the first human experience with the Biolimus A9 drug-eluting stent for de novo coronary lesionsRicardo A Costa
The Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York, USA
Am J Cardiol 98:443-6. 2006..14 +/- 0.45 vs 0.40 +/- 0.41 mm, p = 0.004). In-stent restenosis was 3.9% in the Biolimus stent group versus 7.7% in the control group (p = 0.40). There was no exaggerated hyperplasia at the proximal and/or distal edge of the stent...
Nonrandomized comparison of coronary stenting under intravascular ultrasound guidance of direct stenting without predilation versus conventional predilation with a semi-compliant balloon versus predilation with a new scoring balloonJose de Ribamar Costa
Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York, USA
Am J Cardiol 100:812-7. 2007..In conclusion, in this observational, nonrandomized study, pretreatment with the AngioSculpt balloon enhanced stent expansion and minimized the difference between predicted and achieved stent dimensions...
Minimally invasive direct coronary artery bypass (MIDCAB) versus coronary artery stenting for elective revascularization of the left anterior descending arteryIoannis Iakovou
Cardiovascular Research Foundation, New York, New York 10022, USA
Am J Cardiol 90:885-7. 2002
Frequency, correlates, and clinical implications of myocardial perfusion after primary angioplasty and stenting, with and without glycoprotein IIb/IIIa inhibition, in acute myocardial infarctionCostantino O Costantini
Cardiovascular Research Foundation and Lenox Hill Hospital, New York, New York, USA
J Am Coll Cardiol 44:305-12. 2004..Neither stents nor GP IIb/IIIa inhibitors significantly enhance myocardial perfusion compared to balloon angioplasty alone, underlying the similar long-term mortality with these different mechanical reperfusion strategies...
Angiographic results of the first human experience with everolimus-eluting stents for the treatment of coronary lesions (the FUTURE I trial)Ricardo A Costa
Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York 10022, USA
Am J Cardiol 95:113-6. 2005..There was 1 in-stent and 1 in-segment (proximal edge) restenosis in the metallic stent group. There was no stent thrombosis or aneurysm formation at follow-up in either group...
SPIRIT IV trial design: a large-scale randomized comparison of everolimus-eluting stents and paclitaxel-eluting stents in patients with coronary artery diseaseEugenia Nikolsky
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY 10022, USA
Am Heart J 158:520-526.e2. 2009..We therefore designed a large-scale randomized trial without angiographic follow-up to further assess the differences between these 2 stent platforms...
Long-term follow-up of patients after gamma intracoronary brachytherapy failure (from GAMMA-I, GAMMA-II, and SCRIPPS-III)Thosaphol Limpijankit
Cardiovascular Research Foundation, New York, New York 10022, USA
Am J Cardiol 92:315-8. 2003..e., drug-eluting stents) are available. Shorter time from brachytherapy to radiation failure and late thrombosis after brachytherapy were independent predictors of adverse events...
Intravascular ultrasound study of patterns of calcium in ruptured coronary plaquesKenichi Fujii
Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York, USA
Am J Cardiol 96:352-7. 2005..In conclusion, ruptured plaques are associated with a larger number of calcium deposits within an arc of <90 degrees , a larger number of deep calcium deposits, and a remodeling index...
Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarctionH Mehrdad Sadeghi
William Beaumont Hospital, Royal Oak, Mich, USA
Circulation 108:2769-75. 2003..Novel approaches are needed to improve the otherwise poor prognosis of patients with RI and AMI...
Results of the Jostent coronary stent graft implantation in various clinical settings: procedural and follow-up resultsUlrich Gercken
Department of Cardiology and Angiology, Heart-Center, Siegburg, Siegburg, Germany
Catheter Cardiovasc Interv 56:353-60. 2002..Covered stents such as the JoMed coronary stent graft may become essential for bailout treatment of coronary perforations...
Predictors of recurrent in-stent restenosis after beta-radiation: An analysis from the START 40/20 trialHideaki Kaneda
Division of Cardiovascular Medicine, Stanford University Medical Center, Stanford, California 94305, USA
J Interv Cardiol 19:376-80. 2006..CONCLUSIONS: Even with adjunct beta-radiation therapy, initial mechanical optimization, such as appropriate balloon sizing and positioning, may be critical for the prevention of recurrent ISR...
Prognostic utility of comparative methods for assessment of ST-segment resolution after primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trialMichael G McLaughlin
Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA
J Am Coll Cardiol 44:1215-23. 2004..The simple measure of the maximal residual degree of STE after primary PCI is a strong independent predictor of both survival and freedom from reinfarction at 30 days and 1 year...
Delivered dose and vascular response after beta-radiation for in-stent restenosis: retrospective dosimetry and volumetric intravascular ultrasound analysisYoshihiro Morino
Center for Research in Cardiovascular Interventions, Stanford University Medical Center, Stanford, Calif 94305-5637, USA
Circulation 106:2334-9. 2002..CONCLUSIONS: The current dose-prescription protocol of (90)Sr/Y radiation to native in-stent restenosis lesions may provide substantial inhibition of neointimal reproliferation regardless of the actual delivered dose intensity...
A trial comparing rheolytic thrombectomy with intracoronary urokinase for coronary and vein graft thrombus (the Vein Graft AngioJet Study [VeGAS 2])Richard E Kuntz
Brigham and Women's Hospital, Boston, Massachusetts 02215, USA
Am J Cardiol 89:326-30. 2002
Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trialJames E Tcheng
Duke Clinical Research Institute, Durham, NC 27705, USA
Circulation 108:1316-23. 2003..However, variations in trial designs, modest sample sizes, and limited long-term follow-up have precluded these studies from being definitive...
Long-term outcome of patients treated with repeat percutaneous coronary intervention after failure of gamma-brachytherapy for the treatment of in-stent restenosisRoss Prpic
Harvard Clinical Research Institute, Boston, Mass 02215, USA
Circulation 106:2340-5. 2002..The short- and long-term outcomes of repeat percutaneous intervention in this population have not been characterized...
Ischemic and bleeding outcomes in women treated with bivalirudin during percutaneous coronary intervention: a subgroup analysis of the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE)-2 trialMatthews Chacko
Cleveland Clinic Foundation, Cleveland, OH 44195, USA
Am Heart J 151:1032.e1-7. 2006....
Two-year clinical follow-up of 90Sr/90 Y beta-radiation versus placebo control for the treatment of in-stent restenosisSigmund Silber
Dr. Mueller Hospital, Munich, Germany
Am Heart J 149:689-94. 2005..0% +/- 3.4% (P = .035). CONCLUSIONS: The START trial shows for the first time that the initial beneficial effects of intracoronary brachytherapy with beta-radiation using 90 Sr/ 90 Y are maintained at 2-year clinical follow-up period...
Prospective, multicenter study of thrombectomy in patients with acute myocardial infarction: the X-Tract AMI registryJohn J Young
Swedish Heart and Vascular Institute, Seattle, Washington, USA
J Interv Cardiol 20:44-50. 2007..Thrombectomy prior to intervention may decrease thromboembolic complications and improve outcomes...
Randomized trial of 90Sr/90Y beta-radiation versus placebo control for treatment of in-stent restenosisJeffrey J Popma
Interventional Cardiology, Brigham and Women s Hospital, Boston, Mass 02115, USA
Circulation 106:1090-6. 2002..We report the first multicenter, blinded, and randomized trial of intracoronary radiation with the use of a 90Sr/90Y beta-source for the treatment of in-stent restenosis...
Outcome in elderly patients undergoing primary coronary intervention for acute myocardial infarction: results from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trialGiulio Guagliumi
Ospedali Riuniti di Bergamo, Bergamo, Italy
Circulation 110:1598-604. 2004..By reducing restenosis, however, stent implantation improves clinical outcomes in elderly patients with AMI...
Coordinated series of studies to evaluate characteristics and mechanisms of acute coronary syndromes in high-risk patients randomly assigned to enoxaparin or unfractionated heparin: design and rationale of the SYNERGY LibraryJohn L Petersen
Division of Cardiology and Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA
Am Heart J 148:269-76. 2004..It is hoped that the SYNERGY Library will serve as a model for future substudy design to maximize academic insight within the framework of a large-scale, multicenter trial...
Favorable effect of gamma-radiation for in-stent restenosis: effect of diabetes on angiographic and clinical outcomesIoannis Iakovou
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York, USA
Catheter Cardiovasc Interv 62:303-7. 2004..DM remains a powerful predictor of TLR and major adverse cardiac events even after treatment of ISR with gamma-RT...
